3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
11
Breast Neoplasms
10
Prostatic Neoplasms
7
Colorectal Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Hematopoietic and Lymphatic System Neoplasm
3
Hematologic Neoplasms
3
Advanced Malignant Solid Neoplasm
3
Skin Carcinoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Obesity-Related Malignant Neoplasm
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Malignant Solid Neoplasm
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Syndrome
1
Substance-Related Disorders
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Psoriasis
1
Primary Myelofibrosis
1
Interventions
Gemcitabine
10
Mitomycin
6
Docetaxel
5
erdafitinib
4
durvalumab
4
BCG Vaccine
4
dodecyl maltoside
3
Cystoscopy
3
ALT-803
2
viscum album peptide
1
tremelimumab
1
pirarubicin
1
monalizumab
1
hydroxycamptothecinum
1
chondroitin sulfate, sodium hyaluronate drug combination
1
Watchful Waiting
1
Transurethral Resection of Bladder
1
Patient Discharge
1
Paclitaxel
1
Mitozytrex
1
Magnetic Resonance Spectroscopy
1
Injections
1
Hyaluronic Acid
1
House Calls
1
Home Care Services
1
Epirubicin
1
Drainage
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
Chondroitin Sulfates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Educational Status
×
90 days
×
Clear all
No trials found.